Nektar Therapeutics Announces Proposed Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 39.84 -1.33 (3.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.17 | 52 Week High | $19.98 | |||
| Open | $40.93 | 52 Week Low | $10.52 | |||
| Day High | $40.98 | P/E | N/A | |||
| Day Low | $39.26 | EPS | $-1.45 | |||
| Volume | 1,048,221 | |||||
